Logo image of MASS

908 DEVICES INC (MASS) Stock Fundamental Analysis

NASDAQ:MASS - Nasdaq - US65443P1021 - Common Stock - Currency: USD

2.61  -0.11 (-4.04%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to MASS. MASS was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. The financial health of MASS is average, but there are quite some concerns on its profitability. MASS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

MASS had negative earnings in the past year.
MASS had a negative operating cash flow in the past year.
In the past 5 years MASS always reported negative net income.
MASS had negative operating cash flow in 4 of the past 5 years.
MASS Yearly Net Income VS EBIT VS OCF VS FCFMASS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 -10M -20M -30M -40M

1.2 Ratios

Looking at the Return On Assets, with a value of -33.76%, MASS is doing worse than 80.00% of the companies in the same industry.
With a Return On Equity value of -45.93%, MASS is not doing good in the industry: 78.33% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -33.76%
ROE -45.93%
ROIC N/A
ROA(3y)-13.42%
ROA(5y)-16.65%
ROE(3y)-16.64%
ROE(5y)-46.41%
ROIC(3y)N/A
ROIC(5y)N/A
MASS Yearly ROA, ROE, ROICMASS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 -50 -100 -150 -200 -250

1.3 Margins

MASS has a better Gross Margin (50.81%) than 86.67% of its industry peers.
In the last couple of years the Gross Margin of MASS has declined.
MASS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.15%
GM growth 5Y-2.15%
MASS Yearly Profit, Operating, Gross MarginsMASS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 50 -50

More info and screens

6

2. Health

2.1 Basic Checks

MASS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MASS has more shares outstanding
Compared to 5 years ago, MASS has more shares outstanding
There is no outstanding debt for MASS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MASS Yearly Shares OutstandingMASS Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 10M 20M 30M
MASS Yearly Total Debt VS Total AssetsMASS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

MASS has an Altman-Z score of -0.34. This is a bad value and indicates that MASS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.34, MASS is doing worse than 78.33% of the companies in the same industry.
MASS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.34
ROIC/WACCN/A
WACC8.79%
MASS Yearly LT Debt VS Equity VS FCFMASS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 4.24 indicates that MASS has no problem at all paying its short term obligations.
MASS has a better Current ratio (4.24) than 72.50% of its industry peers.
MASS has a Quick Ratio of 3.54. This indicates that MASS is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of MASS (3.54) is better than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.24
Quick Ratio 3.54
MASS Yearly Current Assets VS Current LiabilitesMASS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

4

3. Growth

3.1 Past

MASS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.40%, which is quite impressive.
MASS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.08%.
Measured over the past years, MASS shows a quite strong growth in Revenue. The Revenue has been growing by 17.90% on average per year.
EPS 1Y (TTM)31.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.18%
Revenue 1Y (TTM)16.08%
Revenue growth 3Y23.16%
Revenue growth 5Y17.9%
Sales Q2Q%17.32%

3.2 Future

The Earnings Per Share is expected to decrease by -1.69% on average over the next years.
Based on estimates for the next years, MASS will show a quite strong growth in Revenue. The Revenue will grow by 19.31% on average per year.
EPS Next Y-70.3%
EPS Next 2Y-7.17%
EPS Next 3Y-1.69%
EPS Next 5YN/A
Revenue Next Year13.48%
Revenue Next 2Y14.78%
Revenue Next 3Y19.31%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
MASS Yearly Revenue VS EstimatesMASS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
MASS Yearly EPS VS EstimatesMASS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MASS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MASS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MASS Price Earnings VS Forward Price EarningsMASS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MASS Per share dataMASS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.17%
EPS Next 3Y-1.69%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MASS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

908 DEVICES INC

NASDAQ:MASS (2/21/2025, 11:26:39 AM)

2.61

-0.11 (-4.04%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)03-11 2025-03-11/amc
Inst Owners73.09%
Inst Owner Change-9.77%
Ins Owners7.63%
Ins Owner Change1.6%
Market Cap90.88M
Analysts85.45
Price Target5.44 (108.43%)
Short Float %6.05%
Short Ratio2.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)61.44%
Min EPS beat(2)9.01%
Max EPS beat(2)113.88%
EPS beat(4)4
Avg EPS beat(4)37.03%
Min EPS beat(4)9.01%
Max EPS beat(4)113.88%
EPS beat(8)6
Avg EPS beat(8)20.83%
EPS beat(12)10
Avg EPS beat(12)18.51%
EPS beat(16)11
Avg EPS beat(16)-40.5%
Revenue beat(2)1
Avg Revenue beat(2)-4.25%
Min Revenue beat(2)-10.3%
Max Revenue beat(2)1.8%
Revenue beat(4)2
Avg Revenue beat(4)-0.92%
Min Revenue beat(4)-10.3%
Max Revenue beat(4)5.41%
Revenue beat(8)5
Avg Revenue beat(8)2.76%
Revenue beat(12)8
Avg Revenue beat(12)2.58%
Revenue beat(16)12
Avg Revenue beat(16)5.11%
PT rev (1m)-5.88%
PT rev (3m)-64.44%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-72.03%
EPS NY rev (1m)0%
EPS NY rev (3m)-51.74%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-25.61%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-10.82%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.65
P/FCF N/A
P/OCF N/A
P/B 0.69
P/tB 1.22
EV/EBITDA N/A
EPS(TTM)-0.83
EYN/A
EPS(NY)-1.3
Fwd EYN/A
FCF(TTM)-0.88
FCFYN/A
OCF(TTM)-0.86
OCFYN/A
SpS1.58
BVpS3.76
TBVpS2.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.76%
ROE -45.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.81%
FCFM N/A
ROA(3y)-13.42%
ROA(5y)-16.65%
ROE(3y)-16.64%
ROE(5y)-46.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.15%
GM growth 5Y-2.15%
F-Score5
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.47%
Cap/Sales 1.35%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.24
Quick Ratio 3.54
Altman-Z -0.34
F-Score5
WACC8.79%
ROIC/WACCN/A
Cap/Depr(3y)97.56%
Cap/Depr(5y)67.44%
Cap/Sales(3y)3.4%
Cap/Sales(5y)2.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%118.18%
EPS Next Y-70.3%
EPS Next 2Y-7.17%
EPS Next 3Y-1.69%
EPS Next 5YN/A
Revenue 1Y (TTM)16.08%
Revenue growth 3Y23.16%
Revenue growth 5Y17.9%
Sales Q2Q%17.32%
Revenue Next Year13.48%
Revenue Next 2Y14.78%
Revenue Next 3Y19.31%
Revenue Next 5YN/A
EBIT growth 1Y17.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-8.1%
EBIT Next 3Y10.95%
EBIT Next 5YN/A
FCF growth 1Y-15.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-19.59%
OCF growth 3YN/A
OCF growth 5YN/A